Gravitational wave science in Europe: from Virgo to Einstein Telescope
Professor Jo van den Brand at the National Institute for Subatomic Physics (Nikhef) discusses developments in the world of gravitational wave science.
Food safety: Assessing mixtures of endocrine disruptors
Alberto Mantovani from Istituto Superiore di Sanità, Roma, Italy, looks at an aspect of food safety that concerns assessing mixtures of endocrine disruptors.
Open Science in Europe: A challenge to benefit all
Frédérique Vidal, Minister of Higher Education, Research, and Innovation in France, weighs up the benefits and challenges of achieving open science in Europe.
Surface functionalization: A tool for biotechnology and health sectors
Professor Sandra Carvalho, University of Minho, Department of Physics, discusses the emergence of surface functionalization as a strategy in biotech and health.
Extending intellectual frontiers in atmospheric and geospace sciences
Here, Open Access Government probes how the National Science Foundation in the U.S. supports extending intellectual frontiers in the atmospheric and geospace sciences.
The RSIF-PASET Programme: Food security and agribusiness at SACIDS Foundation
Here, Professor Gerald Misinzo and Professor Mark Rweyemamu discuss the potential of the RSIF-PASET Programme.
OPRECOMP: Transprecision computing for energy efficiency
Cristiano Malossi, PhD, Manager AI Automation at IBM Research – Zurich tells us what we need to know about the OPRECOMP project that concerns transprecision computing for energy efficiency.
Indigenous youth resilience: Water protectors
Dr Dawn Martin-Hill and Dr Christine Wekerle from McMaster University highlight Indigenous youth resilience research, including comment on what water teaches us.
“Space 2.0” and the problem of orbital debris
Dr David Carroll from CU Aerospace LLC says that there are advantages to nano-satellites and the Space 2.0 environment, but they exacerbate the problem of orbital debris.
JPND: The largest global collaborative initiative for neurodegenerative disease research
Chairman for the global initiative EU Joint Programme – Neurodegenerative Disease Research (JPND) Professor Philippe Amouyel brings to light their innovative work in neurodegenerative disease research.
Nanotechnology: Modern innovation demands regulatory preparedness in risk governance
Monique Groenewold discusses how modern innovation requires regulatory preparedness in risk governance, especially for nanotechnology.
Future machines to explore new frontiers in particle physics
Jim Siegrist from the Office of Science at the U.S. Department of Energy, charts how future machines will explore new frontiers in particle physics.
Rethinking Type 1 diabetes with a radically new immunotherapy approach
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
LRG1: An emerging therapeutic target for the treatment of microvascular dysfunction
John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.
Computer science, software and mathematics: Interactive proof assistants
Dr Nicolas Tabareau from IMT Atlantique Bretagne-Pays de la Loire, provides us with further insight about interactive proof assistants, within the wider field of computer science, software and mathematics.
Doubly charged atomic negative ions for efficient tunable water oxidation to hydrogen peroxide
Drs Alfred Msezane and Kelvin Suggs discuss the possibilities of efficient tunable water oxidation to peroxide catalyzed by doubly charged atomic negative ions.
More organs may be suitable for transplantation with new perfusion method
More donated organs may become suitable for transplantation with a new perfusion method trialled by the EU-funded COPE project.
Digital twins – are they game-changers in clinical research and clinical care?
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores if digital twins are game-changers in clinical research and clinical care.
Industrial policy including secure access to raw materials for batteries
Carlos Trias Pintó explains the European Economic and Social Committee’s stance on industrial policy, including strategies to secure access to raw materials for batteries.
Cambridge COVID-19 vaccine gets £1.9 million to start trials
The University of Cambridge are developing a COVID-19 vaccine, which is expected to start clinical trials in Autumn 2020.
